BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bertrand J, Caillol F, Borentain P, Raoul JL, Heyries L, Bories E, Pesenti C, Ratone JP, Bernard JP, Gerolami R, Giovannini M. Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients. Hepat Med 2015;7:21-7. [PMID: 26056497 DOI: 10.2147/HMER.S67940] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Xue W, Xu P, Deng Z, Duan C, Zhang D, Zheng S, Cui K, Qiu X. Efficacy on radiofrequency ablation according to the types of benign thyroid nodules. Sci Rep 2021;11:22270. [PMID: 34782643 DOI: 10.1038/s41598-021-01593-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Li HZ, Tan J, Tang T, An TZ, Li JX, Xiao YD. Chemoembolization Plus Microwave Ablation vs Chemoembolization Alone in Unresectable Hepatocellular Carcinoma Beyond the Milan Criteria: A Propensity Scoring Matching Study. J Hepatocell Carcinoma 2021;8:1311-22. [PMID: 34754838 DOI: 10.2147/JHC.S338456] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Scheck J, Bruners P, Schindler D, Kuhl C, Isfort P. Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation. Korean J Radiol 2018;19:560-7. [PMID: 29962862 DOI: 10.3348/kjr.2018.19.4.560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Zheng L, Li HL, Guo CY, Luo SX. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas. Korean J Radiol 2018;19:237-46. [PMID: 29520181 DOI: 10.3348/kjr.2018.19.2.237] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
5 Qi X, Li G, Liu D, Motamarry A, Huang X, Wolfe AM, Helke KL, Haemmerich D, Staveley-O'Carroll KF, Kimchi ET. Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer. Cancer Biol Ther 2015;16:1812-9. [PMID: 26537481 DOI: 10.1080/15384047.2015.1095412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]